申请人:Sterling Drug Inc.
公开号:US04182759A1
公开(公告)日:1980-01-08
Arylalkyl and aryloxyalkylphosphonates, useful as antiviral agents, are prepared by reacting an arylalkyl or aryloxyalkyl halide with a trialkyl phosphite, or with an alkali metal salt of a dialkyl phosphonate, trialkyl phosphonoalkanoate or dialkyl phosphonoalkanone.
芳基烷基和芳氧烷基膦酸酯,作为抗病毒剂有用,通过将芳基烷基或芳氧烷基卤化物与三烷基膦酸酯,或与二烷基膦酸酯、三烷基膦酸酯烷酸酯或二烷基膦酸酯烷酮的碱金属盐反应而制备。